Tomiteru Togano

588 total citations
40 papers, 386 citations indexed

About

Tomiteru Togano is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Tomiteru Togano has authored 40 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Infectious Diseases and 11 papers in Molecular Biology. Recurrent topics in Tomiteru Togano's work include Fungal Infections and Studies (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Tomiteru Togano is often cited by papers focused on Fungal Infections and Studies (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Tomiteru Togano collaborates with scholars based in Japan, United States and Switzerland. Tomiteru Togano's co-authors include Hikaru Kume, Masaaki Higashihara, Ryouichi Horie, Mariko Watanabe, Toshiki Watanabe, Hitoshi Ohto, Makoto Nakashima, Michiko Abe, Kazuo Umezawa and H. Tanuma and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Tomiteru Togano

36 papers receiving 375 citations

Peers

Countries citing papers authored by Tomiteru Togano

Since Specialization

Citations

This map shows the geographic impact of Tomiteru Togano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomiteru Togano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomiteru Togano more than expected).

Fields of papers citing papers by Tomiteru Togano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomiteru Togano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomiteru Togano. The network helps show where Tomiteru Togano may publish in the future.

Co-authorship network of co-authors of Tomiteru Togano

This figure shows the co-authorship network connecting the top 25 collaborators of Tomiteru Togano. A scholar is included among the top collaborators of Tomiteru Togano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomiteru Togano. Tomiteru Togano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Duration of infectious virus shedding of SARS-CoV-2 Omicron variant among immunocompromised patients 2025 ·Journal of Infection and Chemotherapy ·(unknown), Naoya Itoh, Masahiro Ishikane, Noriko Iwamoto, Yusuke Asai, (unknown), (unknown), (unknown), Masayuki Hojo, Akira Hangaishi, Tomiteru Togano, Katsuji Teruya, Kenichiro Takahashi, Shô Miyamoto, Yuichiro Hirata, Takayuki Kanno, Tomoya Saito, Harutaka Katano, Tadaki Suzuki, Norio Ohmagari	2
2	Retrospective analysis of treatment discontinuation in minimal residual disease negative multiple myeloma 2025 ·International Journal of Hematology ·(unknown), (unknown), (unknown), (unknown), Tomiteru Togano, Yotaro Tamai	0
3	Real-world effectiveness and safety of rituximab and reduced-dose CHP with polatuzumab vedotin (pola-R-CHP) in patients aged > 80 years with diffuse large B-cell lymphoma: a retrospective analysis 2025 ·Blood Research ·(unknown), (unknown), (unknown), Tomiteru Togano, Yotaro Tamai	4
4	A novel protocol for de-isolating moderately and severely immunocompromised COVID-19 patients 2023 ·Global Health & Medicine ·(unknown), Noriko Iwamoto, Masahiro Ishikane, Kei Yamamoto, (unknown), (unknown), Akira Hangaishi, Hiroshi Shimazu, Tomiteru Togano, Hiroyuki Yamashita, Yasuhide Yamada, Norio Ohmagari	3
5	Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan 2021 ·International Journal of Infectious Diseases ·Hisao Hara, Yukari Uemura, Kayoko Hayakawa, Tomiteru Togano, Yusuke Asai, Nobuaki Matsunaga, Mari Terada, Hiroshi Ohtsu, Koji Kitajima, (unknown), (unknown), Masahiro Ishikane, (unknown), Taro Shibata, Masashi Kondo, Kazuo Izumi, Wataru Sugiura, Norio Ohmagari	2
6	The evaluation of Cannabidiol’s effect on the immunotherapy of Burkitt lymphoma 2019 ·Biochemical and Biophysical Research Communications ·Tomiteru Togano, (unknown), Natalie Kim, (unknown), (unknown), (unknown), Jino Park	5
7	AF1q inhibited T cell attachment to breast cancer cell by attenuating Intracellular Adhesion Molecule-1 expression 2019 ·Journal of Cancer Metastasis and Treatment ·Jino Park, Jae Yeon Hwang, (unknown), Soo‐Jin Kim, Tomiteru Togano, Shotaro Hagiwara, Juw Won Park, William Tse	4
8	Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch 2019 ·Stem Cell Reviews and Reports ·(unknown), Jiaqi Shen, Kevin G. Pinz, M. Wada, Jino Park, Soojin Kim, Tomiteru Togano, William Ka Fai Tse	48
9	Infectious diseases in solid organ transplant recipients: Analysis of autopsied cases in Japan 2017 ·Journal of Infection and Chemotherapy ·(unknown), Akira Kenjo, Tomiteru Togano, Natsuo Yamamoto, Hitoshi Ohto, Hikaru Kume	5
10	Epidemiology of visceral mycoses in autopsy cases in Japan: the data from 1989 to 2009 in the Annual of Pathological Autopsy Cases in Japan 2013 ·Medical Mycology ·(unknown), Hikaru Kume, Tomiteru Togano, Yuhsaku Kanoh, Hitoshi Ohto	36
11	Lenalidomide-induced acute lung injury in case of multiple myeloma 2013 ·International Journal of Clinical Pharmacology and Therapeutics ·Mikio Danbara, (unknown), Tomiteru Togano, (unknown), (unknown), Kôji Miyazaki, Masaaki Higashihara	1
12	Estimated Numbers of Visceral Mycoses in Case of Leukemia and MDS in Japan : Analysis of the data from the Annual of the pathological autopsy cases and vital statics in Japan 2012 ·Medical Mycology Journal ·Tomiteru Togano, Kazutoshi Shibuya, Hikaru Kume	3
13	Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL 2012 ·Annals of Hematology ·(unknown), Tsutomu Yoshida, Guoqin Wang, Tomiteru Togano, Shunsuke Miyamoto, Kôji Miyazaki, Keiichi Iwabuchi, Meijin Nakayama, Ryouichi Horie, Nozomi Niitsu, Yuichi Sato, Naoya Nakamura	22
14	Ets-1 Activates Overexpression of JunB and CD30 in Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma 2011 ·American Journal Of Pathology ·Mariko Watanabe, Kinji Itoh, Tomiteru Togano, Marshall E. Kadin, Toshiki Watanabe, Masaaki Higashihara, Ryouichi Horie	24
15	Targeted Repression of Overexpressed CD30 Downregulates NF-κB and ERK1/2 Pathway in Hodgkin Lymphoma Cell Lines 2011 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·Mariko Watanabe, Kazumi Nakano, Tomiteru Togano, Makoto Nakashima, Masaaki Higashihara, Marshall E. Kadin, Toshiki Watanabe, Ryouichi Horie	21
16	The side population, as a precursor of Hodgkin and Reed‐Sternberg cells and a target for nuclear factor‐κB inhibitors in Hodgkin’s lymphoma 2010 ·Cancer Science ·Makoto Nakashima, Yumiko Ishii, Mariko Watanabe, Tomiteru Togano, Kazuo Umezawa, Masaaki Higashihara, Toshiki Watanabe, Ryouichi Horie	15
17	A case of giardiasis expressing severe systemic symptoms and marked hypereosinophilia 2010 ·Parasitology International ·(unknown), Takeshi Nakamura, Masaharu Tokoro, Tomiteru Togano, (unknown), Mika Kohri, (unknown), Kôji Miyazaki, Mikio Danbara, Ryouichi Horie, Ikuo Miura, Keisuke Sunakawa, Masaaki Higashihara	4
18	Identification of the RelA domain responsible for action of a new NF-κB inhibitor DHMEQ 2008 ·Biochemical and Biophysical Research Communications ·Mariko Watanabe, Makoto Nakashima, Tomiteru Togano, Masaaki Higashihara, Toshiki Watanabe, Kazuo Umezawa, Ryouichi Horie	32
19	Splenic Infarction after Epstein-Barr Virus Infection in a Patient with Hereditary Spherocytosis 2007 ·International Journal of Hematology ·(unknown), Tsutomu Shichishima, (unknown), (unknown), (unknown), Ryouichi Horie, Tomiteru Togano, Kôji Miyazaki, Masaaki Ichinoe, Keiichi Iwabuchi, Hisaichi Fujii, Masaaki Higashihara	24
20	Development of hepatosplenic γδ T‐cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature 2004 ·European Journal Of Haematology ·Nozomi Niitsu, Mika Kohri, Tomiteru Togano, Hirokazu Nakamine, Shigeo Nakamura, Keiichi Iwabuchi, Masaaki Higashihara	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact